2 top ASX growth shares that might be worth buying

Volpara is one of the top ASX growth shares to consider.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors may be interested in some ASX growth shares that have been delivering underlying growth for a while now.

Businesses that are achieving good revenue growth may be able to grow profit nicely over the coming years. Profit can be a key driver of share price growth over time.

That's why these two leading ASX growth shares could be quality ideas to think about:

ASX shares Business man marking buy on board and underlining it

Image Source: Getty Images

Volpara Health Technologies Ltd (ASX: VHT)

Volpara is a healthcare technology business that provides software relating to screening for breast cancer and screening for lung cancer.

In the first quarter of FY22, Volpara reported that its subscription-based cash receipts were up around 38% to NZ$6.1 million. In constant currency terms, this was an increase of 60%.

Volpara is seeing steady growth in multiple areas. For example, its coverage of US women being screened was 33%, up from the prior quarter of 32%. Not only is the market share of women increasing, but the average revenue per user (ARPU) is also rising.

ARPU in that FY22 first quarter was US$1.42, an increase from US$1.40 at the end of the fourth quarter of FY21. The average ARPU for the first quarter was US$1.55. ARPU of up to US$5.87 was achieved at some sites.

Volpara's client loyalty remains high, with software as a service (SaaS) churn continuing to remain low.

The ASX growth share has a very high gross profit margin – it was 91% in FY21. This means that a lot of the new revenue can translate into gross profit.

The acquisition of CRA Health and expansion in the US lung cancer screening market are both promising. Volpara Lung currently covers around 8% of US lung cancer screening.

Betashares Asia Technology Tigers ETF (ASX: ASIA)

Over six months, this exchange-traded fund (ETF) has fallen 14%. But that gives investors the opportunity to look at it at a lower valuation.

The purpose of this investment is to give exposure to 50 of the largest Asian technology businesses outside of Japan in a single portfolio.

BetaShares says that:

Due to its younger, tech-savvy population, Asia is surpassing the West in terms of technological adoption and the sector is anticipated to remain a growth sector.

The ETF provider also points out that this investment can be used as a complement for investors to get Asian tech exposure alongside the US

So what's actually in the portfolio? There are six positions with a weighting of more than 5%: Taiwan Semiconductor Manufacturing (11.4%), Samsung Electronics (10%), Tencent (9.8%), Alibaba (8.7%), Meituan (6.6%) and Sea (5.7%). The other top 10 positions all have a weighting of at least 3%: JD.com (4.9%), Infosys (4.7%), Pinduoduo (4.4%) and Netease (3%).

These businesses come from a range of different sectors. E-commerce, semiconductors, gaming, technology hardware, entertainment, IT consulting and so on are all represented.

It has an annual management fee of 0.67%. Despite that fee, since inception to August 2018, it had produced an average return per annum of almost 23%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia owns shares of and has recommended BetaShares Asia Technology Tigers ETF and VOLPARA FPO NZ. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

A woman is excited as she reads the latest rumour on her phone.
Growth Shares

Here's why experts rate these ASX 200 growth shares as buys

Healthcare, retail, and lithium... here's why analysts rate these growth shares highly right now.

Read more »

A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
Broker Notes

Morgans names the best ASX 200 growth shares to buy in March

These growth shares have been tipped for big things by a leading broker...

Read more »

a small child and a pug dog sit in a go cart wearing old fashioned drivers headress and goggles as the drive along a country road with the boy holding his arm in the air and shouting as if celebrating their performance behind the wheel.
Growth Shares

Top ASX growth shares to buy in March 2023

Could these growth stocks be set to hit the accelerator?

Read more »

A businessman hugs his computer and smiles.
Growth Shares

Buy and hold these ASX 200 shares: brokers

These could be great options for investors looking for buy and hold investments.

Read more »

A man sees some good news on his phone and gives a little cheer.
Growth Shares

Analysts say these exciting ASX growth shares are buys this month

These could be the growth shares to buy right now according to analysts.

Read more »

A boy is about to rocket from a copper-coloured field of hay into the sky.
Growth Shares

2 explosive ASX growth shares to buy this month: analysts

There are different levels of growth and these shares are in the clouds...

Read more »

A man sees some good news on his phone and gives a little cheer.
Growth Shares

2 ASX growth shares to buy: Goldman Sachs

Goldman Sachs believes these ASX shares are well-positioned for strong growth.

Read more »

A young man sits at his desk working on his laptop with a big smile on his face due to his ASX shares going up and in particular the Computershare share price
Growth Shares

These are the ASX 200 shares to buy in March: experts

Now could be the time to pounce on these ASX 200 shares.

Read more »